Best Practice & Research Clinical Haematology
Volume 22, Issue 3 , Pages 409-429, September 2009

Management of Drug Toxicities in Chronic Myeloid Leukaemia

  • Michael J. Mauro, MD (Associate Professor)

      Affiliations

    • Knight Cancer Institute, Center For Hematologic Malignancies, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, UHN-73C, Portland, OR 97239, USA
    • Corresponding Author InformationCorresponding author. Tel.: +503 494 0376; Fax: +503 494 7386.
    • ,
  • Michael W. Deininger, MD, PhD (Associate Professor)

      Affiliations

    • Knight Cancer Institute, Center For Hematologic Malignancies, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, BRB-511, Portland, OR 97239, USA
    • Tel.: +503 494 1603; Fax: +503 494 3688.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(09)00033-4

doi:10.1016/j.beha.2009.06.001

Best Practice & Research Clinical Haematology
Volume 22, Issue 3 , Pages 409-429, September 2009

Article Tools

* Image Usage & Resolution